Sympathetic Nervous System Involvement in Essential Hypertension: Increased Platelet Noradrenaline Coincides with Decreased β-Adrenoreceptor Responsiveness

References

• Da Prada M, Picotti G B. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol 1979; 65: 653–63
   PubMed Web of Science ®Google Scholar
• Picotti G B, Cesura A M, Galva M D, Mantegazza P, Kettler R, Da Prada M. Monoamine sulfoconjugation by human platelets. Phenolsul-fotransferase in mental health research, E Usdin, M Sandler. MacMillan, New York 1981; 44–54
   Google Scholar
• McCulloch R K, Vandongen R, Tunney A M, Beilin L J, Rogers P B. Distribution of free and sulfate-conjugated catecholamines in human platelets. Am J Physiol 1987; 253: E312–6
   Google Scholar
• Gordon J L, Olverman H J. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets. Br J Pharmacol 1978; 62: 219–6
   PubMed Web of Science ®Google Scholar
• Zweifler A J, Julius S. Increased platelet catecholamine content in pheochromocytoma. N Engl J Med 1982; 306: 89–94
   Google Scholar
• Rosen S G, Sanfield J A, Morrow L A, Zweifler A J. Relationship between plasma and platelet epinephrine concentrations in human. Am J Physiol 1987; 252: E334–9
   Google Scholar
• Kjeldsen S E, Westheim A, Lande K, et al. Sodium depletion increases platelet and plasma catecholamines in hypertensive men. Hypertension 1988; 11: 477–82
   Google Scholar
• Smith C CT, Curtis L D, Delamothe A P, Prichard B NC, Betteridge D J. The distribution of catecholamines between platelets and plasma in normal human subjects. Clin Sci 1985; 69: 1–6
   Web of Science ®Google Scholar
• Zweifler A J, Fedorak I, Borondy M. Determinants of platelet catecholamine content: uptake and retention of catecholamies by human platelets in vitro. Platelets 1990; 1: 91–4
   Google Scholar
• Goldstein D S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983; 5: 86–99
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Gjesdal K, Leren P, Eide I. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension. Thromb Haemost 1988; 60: 251–4
   Google Scholar
• Kjeldsen S E, Neubig R R, Weder A B, Zweifler A J. The hypertension—coronary heart disease dilemma: the catecholamine—blood platelet connection. Editorial review. J Hypertens 1989; 7: 851–60
   Google Scholar
• Lande K, Os I, Kjeldsen S E, et al. Increased platelet size and release reaction in essential hypertension. J Hypertens 1987; 5: 401–6
   PubMed Web of Science ®Google Scholar
• Rostrup M, Mundal H H, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens 1991; 9: 159–66
   PubMed Web of Science ®Google Scholar
• Gomi T, Ikeda T, Sakurai J, Nakayama D, Ikegami F. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension. J Hypertens 1988; 6: 389–92
   PubMedGoogle Scholar
• Hjemdahl P, Åkerstedt T, Pollare T, Gillberg M. Influence β-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand 1983; 45–53, Suppl 515
   Google Scholar
• Ekeberg Ø, Kjeldsen S E, Eide I K, Greenwood D T, Enger E. Effects of β1-and β2-blockade on blood pressure and sympathetic responses to flight phobia stress. Clin Pharmacol Ther 1990; 47: 599–607
   Google Scholar
• Cryer P E. Regulation of glucose metabolism in man. J Intern Med 1991; 229(Suppl 2)31–9
   Google Scholar
• Body J-J, Cryer P E, Offord K P, Heath H. Epinephrine is a hypophosphatemic hormone in man. J Clin Invest 1983; 71: 572–8
   PubMedGoogle Scholar
• Kjeldsen S E, Os I, Westheim A, et al. Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone. Am J Hypertens 1988; 1: 403–9
   PubMed Web of Science ®Google Scholar
• Ljunghall S, Joborn H, Rastad J, Åkerström G. Plasma potassium and phosphate concentrations—influence by adrenaline infusion, β-blockade and physical exercise. Acta Med Scand 1987; 221: 83–93
   PubMedGoogle Scholar
• Julius S, Mejia A, Jones K, et al. “White coat” verus “psustained” borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16: 617–23
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Moan A, Petrin J, Weder A B, Zweifler A J, Julius S. Evaluation of self-measured home vs. clinic intra-arterial blood pressure. Blood Pressure 1993; 2: 28–34
   PubMedGoogle Scholar
• Peuler J D, Johnson G A. Simultaneous single radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36
   PubMed Web of Science ®Google Scholar
• Gupta R K, Kjeldsen S E, Motley E, Weder A B, Zweifler A J, Julius S. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. J Cardiovasc Pharmacol 1991; 17: 13–9
   PubMedGoogle Scholar
• Folkow B. Psychosocial and central nervous influences in primary hypertension. Circulation 1987; 76(Suppl 1)10–9
   Google Scholar
• Reis D J, Ledoux J E. Some central neural mechanism governing resting and behaviourally coupled control of blood pressure. Circulation 1987; 76(Suppl 1)2–9
   Google Scholar
• Julius S, Pascual A V, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 44: 413–8
   PubMed Web of Science ®Google Scholar
• Julius S. Schork N, Schork A. Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set. J Cardiovasc Pharmacol 1988; 12(Suppl 3)121–9
   Google Scholar
• Bristow J D, Hornour A J, Pickering G W, Sleight P, Smyth H S. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39: 38–54
   Google Scholar
• O'Rourke M F. Basic concepts for the understanding of large arteries in hypertension. J Cardiovasc Pharmacol 1985; 7(Suppl 2)14–21
   Google Scholar
• Wiggers C J. Studies on cardiodynamic actions of drugs: mechanism of cardiac stimulation by epinephrine. J Pharmacol Exp Ther 1927; 30: 233–50
   Google Scholar
• Opdyke D F. Effect of changes in initial tension, initial volume and epinephrine on ventricular relaxation process. Am J Physiol 1952; 169: 403, 11
   Google Scholar
• Julius S, Randall O S, Esler M D, Kashima T, Ellis C, Bennett J. Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res 1975; 36/37(Suppl 1)199–207
   Google Scholar
• Safar M E, London G M, Weiss Y A, Milliez P L. Vascular reactivity to norepinephrine and hemodynamic parameters in borderline hypertension. Am Heart J 1975; 89: 480–6
   PubMed Web of Science ®Google Scholar
• Bertel O, Bühler F R, Kiowski W, Lutold B E. Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980; 2: 130–8
   PubMed Web of Science ®Google Scholar
• Trimarco B, Volpe M, Ricciardelli B, et al. Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. Hypertension 1983; 5: 584–90
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Esler M D, Cox H S, et al. Differences in the neuronal removal of circulating epinephrine and norepinephrine. J Clin Endocrinol Metab 1990; 70: 1710–20
   Google Scholar
• Mattiasson I, Ohlin H. Sodium and noradrenaline effluxes from platelets in male relatives to hypertensive individuals. Clin Exp Hypertens 1987; A9: 1859–73
   Google Scholar
• Hjemdahl P, Fagius J, Freyschuss U, et al. Muscle sympathetic activity and norepinephrine release during mental challenge in humans. Am J Physiol 1989; 257: E654–64
   PubMed Web of Science ®Google Scholar
• Sowers J R. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J Clin Endocrinol Metab 1981; 53: 1133–7
   PubMed Web of Science ®Google Scholar
• Lande K, Gjesdal K, Fønstelien E, Kjeldsen S E, Eide I. Effects of adrenaline infusion on platelet number, volume and release reaction. Thromb Haemost 1985; 54: 450–3
   PubMed Web of Science ®Google Scholar
• Rand M J, Majewski H, Tung L H. Activation of prejunctional β-adrenoceptors by adrenaline acting as a cotransmitter: a possible cause of hypertension. Drugs 1983; 25(Suppl 2)64–8
   Web of Science ®Google Scholar
• Persson B, Andersson O K, Hjemdahl P, Wysocki M, Agerwall S, Wallin G. Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. J Hypertens 1989; 7: 747–56
   Google Scholar
• Rostrup M, Kjeldsen S E, Eide I. Awareness of hypertension increases blood pressure and sympathetic responses to cold pressure test. Am J Hypertens 1990; 3: 912–7
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Gjesdal K, Eide I, et al. Increased β-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369–73
   PubMed Web of Science ®Google Scholar
• Gleerup G, Winther K. The effect of aging on human platelet sensitivity to serotonin. Eur J Clin Invest 1988; 18: 504–6
   PubMed Web of Science ®Google Scholar
• Ellingsen Ø, Vengen Ø A, Kjeldsen S E, Eide I, Ilebekk A. Myocardial potassium uptake and catecholamine release during cardiac sympathetic nerve stimulation. Cardiovasc Res 1987; 21: 892–901
   Google Scholar
• Westheim A, Os I, Kjeldsen S E, Fønstelien E, Eide I. Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension. Scand J Clin Lab Invest 1990; 50: 815–22
   PubMed Web of Science ®Google Scholar
• Morlin C, Wallin B G, Eriksson B M. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand 1983; 119: 117–21
   PubMedGoogle Scholar